Procter & Gamble Hygiene and Health Care Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: November 10, 2025, 1:05 pm

Competitors of Procter & Gamble Hygiene and Health Care Ltd

All Competitor Stocks of Procter & Gamble Hygiene and Health Care Ltd

Quarterly Result

Last Updated: August 2, 2025, 1:15 am

Below is a detailed analysis of the quarterly data for Procter & Gamble Hygiene and Health Care Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 937.00 Cr.. The value appears to be declining and may need further review. It has decreased from 992.00 Cr. (Mar 2025) to 937.00 Cr., marking a decrease of 55.00 Cr..
• For Expenses, as of Jun 2025, the value is 671.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 782.00 Cr. (Mar 2025) to 671.00 Cr., marking a decrease of 111.00 Cr..
• For Operating Profit, as of Jun 2025, the value is 266.00 Cr.. The value appears strong and on an upward trend. It has increased from 210.00 Cr. (Mar 2025) to 266.00 Cr., marking an increase of 56.00 Cr..
• For OPM %, as of Jun 2025, the value is 28.00%. The value appears strong and on an upward trend. It has increased from 21.00% (Mar 2025) to 28.00%, marking an increase of 7.00%.
• For Other Income, as of Jun 2025, the value is 8.00 Cr.. The value appears to be declining and may need further review. It has decreased from 19.00 Cr. (Mar 2025) to 8.00 Cr., marking a decrease of 11.00 Cr..
• For Interest, as of Jun 2025, the value is 0.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 6.00 Cr. (Mar 2025) to 0.00 Cr., marking a decrease of 6.00 Cr..
• For Depreciation, as of Jun 2025, the value is 9.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 10.00 Cr. (Mar 2025) to 9.00 Cr., marking a decrease of 1.00 Cr..
• For Profit before tax, as of Jun 2025, the value is 265.00 Cr.. The value appears strong and on an upward trend. It has increased from 213.00 Cr. (Mar 2025) to 265.00 Cr., marking an increase of 52.00 Cr..
• For Tax %, as of Jun 2025, the value is 27.00%. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 27.00%.
• For Net Profit, as of Jun 2025, the value is 192.00 Cr.. The value appears strong and on an upward trend. It has increased from 156.00 Cr. (Mar 2025) to 192.00 Cr., marking an increase of 36.00 Cr..
• For EPS in Rs, as of Jun 2025, the value is 59.17. The value appears strong and on an upward trend. It has increased from 48.09 (Mar 2025) to 59.17, marking an increase of 11.08.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: August 22, 2025, 4:16 pm

Growth

Last Updated: September 4, 2025, 9:30 pm

Balance Sheet

Last Updated: November 9, 2025, 1:30 pm

Below is a detailed analysis of the balance sheet data for Procter & Gamble Hygiene and Health Care Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:

• For Equity Capital, as of Sep 2025, the value is 32.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 32.00 Cr..
• For Reserves, as of Sep 2025, the value is 899.00 Cr.. The value appears strong and on an upward trend. It has increased from 705.00 Cr. (Mar 2025) to 899.00 Cr., marking an increase of 194.00 Cr..
• For Borrowings, as of Sep 2025, the value is 2.00 Cr.. The value remains steady. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. There is no change compared to the previous period (Mar 2025) which recorded 2.00 Cr..
• For Other Liabilities, as of Sep 2025, the value is 1,200.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1,015.00 Cr. (Mar 2025) to 1,200.00 Cr., marking an increase of 185.00 Cr..
• For Total Liabilities, as of Sep 2025, the value is 2,133.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1,755.00 Cr. (Mar 2025) to 2,133.00 Cr., marking an increase of 378.00 Cr..
• For Fixed Assets, as of Sep 2025, the value is 166.00 Cr.. The value appears strong and on an upward trend. It has increased from 131.00 Cr. (Mar 2025) to 166.00 Cr., marking an increase of 35.00 Cr..
• For CWIP, as of Sep 2025, the value is 14.00 Cr.. The value appears to be declining and may need further review. It has decreased from 41.00 Cr. (Mar 2025) to 14.00 Cr., marking a decrease of 27.00 Cr..
• For Investments, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
• For Other Assets, as of Sep 2025, the value is 1,953.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,583.00 Cr. (Mar 2025) to 1,953.00 Cr., marking an increase of 370.00 Cr..
• For Total Assets, as of Sep 2025, the value is 2,133.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,755.00 Cr. (Mar 2025) to 2,133.00 Cr., marking an increase of 378.00 Cr..

Notably, the Reserves (899.00 Cr.) exceed the Borrowings (2.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Mutual Fund Holdings

Key Financial Ratios

After reviewing the key financial ratios for Procter & Gamble Hygiene and Health Care Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Jun 24) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 196.11. This value is within the healthy range. It has decreased from 207.95 (Jun 24) to 196.11, marking a decrease of 11.84.
• For Diluted EPS (Rs.), as of Mar 25, the value is 196.11. This value is within the healthy range. It has decreased from 207.95 (Jun 24) to 196.11, marking a decrease of 11.84.
• For Cash EPS (Rs.), as of Mar 25, the value is 205.96. This value is within the healthy range. It has decreased from 225.36 (Jun 24) to 205.96, marking a decrease of 19.40.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 227.04. It has decreased from 238.71 (Jun 24) to 227.04, marking a decrease of 11.67.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 227.04. It has decreased from 238.71 (Jun 24) to 227.04, marking a decrease of 11.67.
• For Dividend / Share (Rs.), as of Mar 25, the value is 175.00. This value exceeds the healthy maximum of 3. It has decreased from 255.00 (Jun 24) to 175.00, marking a decrease of 80.00.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 1,039.56. It has decreased from 1,295.66 (Jun 24) to 1,039.56, marking a decrease of 256.10.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 279.85. This value is within the healthy range. It has decreased from 315.00 (Jun 24) to 279.85, marking a decrease of 35.15.
• For PBIT / Share (Rs.), as of Mar 25, the value is 270.01. This value is within the healthy range. It has decreased from 297.59 (Jun 24) to 270.01, marking a decrease of 27.58.
• For PBT / Share (Rs.), as of Mar 25, the value is 265.61. This value is within the healthy range. It has decreased from 289.34 (Jun 24) to 265.61, marking a decrease of 23.73.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 196.12. This value is within the healthy range. It has decreased from 207.95 (Jun 24) to 196.12, marking a decrease of 11.83.
• For PBDIT Margin (%), as of Mar 25, the value is 26.92. This value is within the healthy range. It has increased from 24.31 (Jun 24) to 26.92, marking an increase of 2.61.
• For PBIT Margin (%), as of Mar 25, the value is 25.97. This value exceeds the healthy maximum of 20. It has increased from 22.96 (Jun 24) to 25.97, marking an increase of 3.01.
• For PBT Margin (%), as of Mar 25, the value is 25.54. This value is within the healthy range. It has increased from 22.33 (Jun 24) to 25.54, marking an increase of 3.21.
• For Net Profit Margin (%), as of Mar 25, the value is 18.86. This value exceeds the healthy maximum of 10. It has increased from 16.05 (Jun 24) to 18.86, marking an increase of 2.81.
• For Return on Networth / Equity (%), as of Mar 25, the value is 86.37. This value is within the healthy range. It has decreased from 87.11 (Jun 24) to 86.37, marking a decrease of 0.74.
• For Return on Capital Employeed (%), as of Mar 25, the value is 102.66. This value is within the healthy range. It has decreased from 110.03 (Jun 24) to 102.66, marking a decrease of 7.37.
• For Return On Assets (%), as of Mar 25, the value is 36.27. This value is within the healthy range. It has decreased from 36.31 (Jun 24) to 36.27, marking a decrease of 0.04.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 1.87. It has decreased from 2.11 (Jun 24) to 1.87, marking a decrease of 0.24.
• For Current Ratio (X), as of Mar 25, the value is 1.23. This value is below the healthy minimum of 1.5. It has increased from 1.22 (Jun 24) to 1.23, marking an increase of 0.01.
• For Quick Ratio (X), as of Mar 25, the value is 0.98. This value is below the healthy minimum of 1. It has decreased from 0.99 (Jun 24) to 0.98, marking a decrease of 0.01.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 15.10. This value exceeds the healthy maximum of 8. It has increased from 3.47 (Jun 24) to 15.10, marking an increase of 11.63.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 104.53. This value exceeds the healthy maximum of 50. It has decreased from 127.43 (Jun 24) to 104.53, marking a decrease of 22.90.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 99.53. This value exceeds the healthy maximum of 50. It has decreased from 117.59 (Jun 24) to 99.53, marking a decrease of 18.06.
• For Earning Retention Ratio (%), as of Mar 25, the value is -4.53. This value is below the healthy minimum of 40. It has increased from -27.43 (Jun 24) to -4.53, marking an increase of 22.90.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 0.47. This value is below the healthy minimum of 40. It has increased from -17.59 (Jun 24) to 0.47, marking an increase of 18.06.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 63.52. This value is within the healthy range. It has increased from 38.18 (Jun 24) to 63.52, marking an increase of 25.34.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 45.52. This value is within the healthy range. It has increased from 26.21 (Jun 24) to 45.52, marking an increase of 19.31.
• For Enterprise Value (Cr.), as of Mar 25, the value is 43,676.26. It has decreased from 53,361.78 (Jun 24) to 43,676.26, marking a decrease of 9,685.52.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 12.94. This value exceeds the healthy maximum of 3. It has increased from 12.69 (Jun 24) to 12.94, marking an increase of 0.25.
• For EV / EBITDA (X), as of Mar 25, the value is 48.08. This value exceeds the healthy maximum of 15. It has decreased from 52.19 (Jun 24) to 48.08, marking a decrease of 4.11.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 13.09. This value exceeds the healthy maximum of 3. It has increased from 12.83 (Jun 24) to 13.09, marking an increase of 0.26.
• For Retention Ratios (%), as of Mar 25, the value is -4.53. This value is below the healthy minimum of 30. It has increased from -27.43 (Jun 24) to -4.53, marking an increase of 22.90.
• For Price / BV (X), as of Mar 25, the value is 59.92. This value exceeds the healthy maximum of 3. It has decreased from 69.63 (Jun 24) to 59.92, marking a decrease of 9.71.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 13.09. This value exceeds the healthy maximum of 3. It has increased from 12.83 (Jun 24) to 13.09, marking an increase of 0.26.
• For EarningsYield, as of Mar 25, the value is 0.01. This value is below the healthy minimum of 5. There is no change compared to the previous period (Jun 24) which recorded 0.01.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness